Save information for later
Sign Up

Learn About Hemangiopericytoma

View Main Condition: Brain Tumor

What is the definition of Hemangiopericytoma?
Hemangiopericytoma is a term used to described a group of tumors that are derived from pericytes, the cells normally arranged along specific types of blood vessels called capillaries and venules. These types of tumors are typically slow-growing, may be either benign (non-cancerous) or malignant (cancerous), and may occur anywhere in the body.
What are the alternative names for Hemangiopericytoma?
  • Hemangiopericytoma
Who are the top Hemangiopericytoma Local Doctors?
Elite in Hemangiopericytoma
Elite in Hemangiopericytoma
Bari, IT 

Angela Sardaro practices in Bari, Italy. Ms. Sardaro and is rated as an Elite expert by MediFind in the treatment of Hemangiopericytoma. Her top areas of expertise are Hemangiopericytoma, Hemangioendothelioma, Hemosiderosis, Prostate Cancer, and Prostatectomy.

Elite in Hemangiopericytoma
Elite in Hemangiopericytoma
U955 Inserm Université Paris Est Créteil, UPEC, 
Creteil, FR 

Caroline Apra practices in Creteil, France. Ms. Apra and is rated as an Elite expert by MediFind in the treatment of Hemangiopericytoma. Her top areas of expertise are Hemangiopericytoma, Solitary Fibrous Tumor, Meningioma, Brain Tumor, and Microvascular Decompression.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Hemangiopericytoma
Distinguished in Hemangiopericytoma

Trustees Of Columbia University In The City Of New York

622 W 168th St, 
New York, NY 
Languages Spoken:
English
Offers Telehealth

Jeffrey Bruce is a Neurosurgery provider in New York, New York. Dr. Bruce and is rated as a Distinguished provider by MediFind in the treatment of Hemangiopericytoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Gamma Knife Radiosurgery, and Awake Craniotomy.

What are the latest Hemangiopericytoma Clinical Trials?
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Diagnosed According to cIMPACT-NOW Recommendations and the 2021 WHO Classification

Summary: Every new classification depends on its prognostic power and on the type of treatment given. With the rapid evolution of diagnostic methods and the advance in new treatments, there is much less reliable information available on how patients with newly defined brain tumour entities should be treated and what to expect from the current treatments. The goal is to determine whether the new 2021 WHO cl...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

Summary: The first proton therapy treatments in the Netherlands have taken place in 2018. Due to the physical properties of protons, proton therapy has tremendous potential to reduce the radiation dose to the healthy, tumour-surrounding tissues. In turn, this leads to less radiation-induced complications, and a decrease in the formation of secondary tumours. The Netherlands has spearheaded the development ...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center